US BROKER MOVES: CRI upgraded at Wells Fargo; ZGN downgraded at Goldman Sachs

UPGRADES Credicorp (BAP) Upgraded to Overweight at Morgan Stanley; PT USD 480 (prev USD 375) Carter’s (CRI) Upgraded to Equalweight at Wells Fargo; PT USD 42 (prev USD 30) Charles River Laboratories (CRL) Upgraded to Overweight at Morgan Stanley; PT USD 220 (prev USD 185) Macerich (MAC) Upgraded to Neutral at JPMorgan; PT USD 25 (prev USD 23) MFA Financial (MFA) Upgraded to Buy at BTIG; PT USD 10.50 AG Mortgage Investment Trust (MITT) Upgraded to Buy at BTIG; PT USD 9 Wabash National (WNC) Upgraded to Buy at DA Davidson DOWNGRADES Cognizant (CTSH) Downgraded to Hold at Berenberg; PT USD 59 (prev USD 81) IQVIA (IQV) Downgraded to Equalweight at Morgan Stanley; PT USD 200 (prev USD 225) Leidos (LDOS) Downgraded to Neutral at BofA Securities; PT USD 125 (prev USD 200) Rexford Industrial Realty (REXR) Downgraded to Underweight at JPMorgan; PT USD 36 (prev USD 38) ResMed (RMD) Downgraded to Equalweight at Morgan Stanley; PT USD 230 (prev USD 286) Grupo Televisa (TV) Downgraded to Reduce at New Street Research; PT USD 2.20 Zegna (ZGN) Downgraded to Neutral at Goldman Sachs; PT USD 14 (prev USD 13.30) INITIATIONS Allegiant Travel (ALGT) Initiated Buy at Goldman Sachs; PT USD 125 Middleby (MIDD) Initiated Outperform at Oppenheimer; PT USD 205 Onto Innovation (ONTO) Initiated Buy at Freedom Broker; PT USD 370 Tyra Biosciences (TYRA) Initiated Buy at Jones Trading; PT USD 56 Western Midstream Partners (WES) Initiated Outperform at Mizuho; PT USD 48